CoChat

The DOI matches its Crossref record; 134 of the 138 references it cites were found in a registry or an index.

Resolution of inflammation in inflammatory bowel disease

Open access
Rogler, Gerhard · 2017 · The Lancet Gastroenterology & Hepatology

Abstract

Treatment of inflammatory bowel disease at present mainly targets mediators of inflammation to stop or suppress pro-inflammatory processes. Typical examples are steroids, suppression of T cells by thioguanine nucleotides, or antibodies against cytokines such as tumour necrosis factor, interleukin 12, or interleukin 23. In addition to suppression of inflammation, development of therapeutic strategies that support resolution of inflammation or that actively resolve inflammation might be desirable. Resolution of inflammation is now seen as an active process involving specific mediators (eg, lipid mediators or specific cytokines) that is mandatory to restore organ function and completely shut down inflammation. The molecular pathways involved in resolution of inflammation have been investigated in recent years and could be adopted in treatment strategies for inflammatory bowel disease. Among these approaches are anti-integrin strategies and means to produce or locally increase restitution or resolution factors, such as restoration of the activity of transforming growth factor-β by anti-SMAD7 antisense oligonucleotides. The potential role of inflammation-resolving lipid mediators (eg, resolvins), however, still warrants further study and clinical development. This Review focuses on the specific role of active resolution of inflammation in inflammatory bowel disease pathophysiology. Potential therapeutic targets based on these pathways are also discussed.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(17)30031-6

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 138 references

Cited by

See all 85

Metadata

Authors
Rogler, G.
Affiliations
University of Zurich (CH)
Corresponding author
Rogler, Gerhard
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2017-07
Volume
2
Issue
7
Pages
521-530
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W2606862276
Cited by
79
References
138
Citations by year
2026: 6 · 2025: 14 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 9 · 2018: 7
FWCI
0.81
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet. Gastroenterology & hepatology (acceptedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Swiss National Science Foundation (3347CO-108792)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
inflammation resolution, inflammatory bowel disease, lipid mediators, resolvins, anti-integrin therapy, TGF-beta, anti-inflammatory therapy, therapeutic target
MeSH terms
Anti-Inflammatory Agents, Environment, Humans, Intestinal Mucosa, Intestines, Macrophages, Neutrophils, Risk Factors, Inflammatory Bowel Diseases, Epigenesis, Genetic, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resolution of inflammation in inflammatory bowel disease. https://app.cochat.ai/papers/10.1016/s2468-1253(17)30031-6
The paper
Rogler, G. (2017). Resolution of inflammation in inflammatory bowel disease. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(17)30031-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.